Ovarian Cancer Global Clinical Trials Review, H2, 2013 -





 Summary 

GlobalData's clinical trial report, “Ovarian Cancer Global Clinical Trials Review, H2, 2013" provides data on the Ovarian Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Ovarian Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Ovarian Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

 Scope 

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

 Reasons to buy 

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Ovarian Cancer 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by BRIC Nations 15
Clinical Trials by G7 Nations 16
Clinical Trials in G7 Nations by Trial Status 17
Clinical Trials by E7 Nations 18
Clinical Trials in E7 Nations by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Unaccomplished Trials of Ovarian Cancer 23
Subjects Recruited Over a Period of Time 42
Prominent Sponsors 43
Top Companies Participating in Ovarian Cancer Therapeutics Clinical Trials 45
Prominent Drug Comparison 47
Clinical Trial Profiles 48
Clinical Trial Overview of Top Companies 48
F. Hoffmann-La Roche Ltd. 48
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 48
GlaxoSmithKline plc 53
Clinical Trial Overview of GlaxoSmithKline plc 53
Sanofi 56
Clinical Trial Overview of Sanofi 56
Eli Lilly and Company 59
Clinical Trial Overview of Eli Lilly and Company 59
AstraZeneca PLC 62
Clinical Trial Overview of AstraZeneca PLC 62
Johnson & Johnson 64
Clinical Trial Overview of Johnson & Johnson 64
Mayo Clinic 66
Clinical Trial Overview of Mayo Clinic 66
Clinical Trial Overview of Top Institutes / Government 68
National Cancer Institute 68
Clinical Trial Overview of National Cancer Institute 68
Gynecologic Oncology Group 94
Clinical Trial Overview of Gynecologic Oncology Group 94
Memorial Sloan Kettering Cancer Center 101
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 101
The University of Texas M. D. Anderson Cancer Center 107
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 107
AGO Ovarian Cancer Study Group 110
Clinical Trial Overview of AGO Ovarian Cancer Study Group 110
Fred Hutchinson Cancer Research Center 113
Clinical Trial Overview of Fred Hutchinson Cancer Research Center 113
Masonic Cancer Center 116
Clinical Trial Overview of Masonic Cancer Center 116
Dana-Farber Cancer Institute, Inc. 118
Clinical Trial Overview of Dana-Farber Cancer Institute, Inc. 118
New York University School of Medicine 120
Clinical Trial Overview of New York University School of Medicine 120
NCIC Clinical Trials Group 121
Clinical Trial Overview of NCIC Clinical Trials Group 121
Five Key Clinical Profiles 123
Appendix 225
Abbreviations 225
Definitions 225
Research Methodology 226
Secondary Research 226
About GlobalData 227
Contact Us 227
Disclaimer 227
Source 228

 

List of Tables

Ovarian Cancer Therapeutics Market, Global, Clinical Trials by Zone, 2013* 7
Ovarian Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 8
Ovarian Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 9
Ovarian Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2013* 10
Ovarian Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2013* 11
Ovarian Cancer Therapeutics Clinical Trials, North America, Top Countries, 2013* 12
Ovarian Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2013* 13
Ovarian Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2013* 14
Ovarian Cancer Therapeutics Clinical Trials, BRIC Countries, 2013* 15
Ovarian Cancer Therapeutics Clinical Trials, G7 Countries, 2013* 16
Ovarian Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 17
Ovarian Cancer Therapeutics Clinical Trials, E7 Countries, 2013* 18
Ovarian Cancer Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 19
Ovarian Cancer Therapeutics Market, Global, Clinical Trials by Phase, 2013* 20
Ovarian Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013* 21
Ovarian Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 22
Ovarian Cancer Therapeutics Market, Global, Suspended Clinical Trials, 2013* 23
Ovarian Cancer Therapeutics Market, Global, Withdrawn Clinical Trials, 2013* 25
Ovarian Cancer Therapeutics Market, Global, Terminated Clinical Trials, 2013* 28
Ovarian Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 42
Ovarian Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 44
Ovarian Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 46
Ovarian Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 47
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2013* 48
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2013* 53
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2013* 56
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2013* 59
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2013* 62
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2013* 64
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2013* 66
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2013* 68
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Gynecologic Oncology Group, 2013* 94
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2013* 101
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2013* 107
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by AGO Ovarian Cancer Study Group, 2013* 110
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2013* 113
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Masonic Cancer Center, 2013* 116
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Dana-Farber Cancer Institute, Inc., 2013* 118
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by New York University School of Medicine, 2013* 120
Ovarian Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by NCIC Clinical Trials Group, 2013* 121

 

List of Figures

Ovarian Cancer Therapeutics Market, Global, Clinical Trials by Zone (%), 2013* 7
Ovarian Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 8
Ovarian Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 9
Ovarian Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2013* 10
Ovarian Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2013* 11
Ovarian Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2013* 12
Ovarian Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2013* 13
Ovarian Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2013* 14
Ovarian Cancer Therapeutics Clinical Trials, BRIC Countries (%), 2013* 15
Ovarian Cancer Therapeutics Clinical Trials, G7 Countries (%), 2013* 16
Ovarian Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 17
Ovarian Cancer Therapeutics Clinical Trials, E7 Countries (%), 2013* 18
Ovarian Cancer Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 19
Ovarian Cancer Therapeutics Market, Global, Clinical Trials by Phase (%), 2013* 20
Ovarian Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013* 21
Ovarian Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 22
Ovarian Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 42
Ovarian Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 43
Ovarian Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 45
Ovarian Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 47
GlobalData Methodology 226